Prevalence, control, and treatment of diabetes, hypertension, and high cholesterol in the Amish
Ryan, Kathleen A
Streeten, Elizabeth A
McArdle, Patrick F
Shuldiner, Alan R
Pollin, Toni I
Mitchell, Braxton D
JournalBMJ open diabetes research & care
PublisherBMJ Publishing Group
MetadataShow full item record
AbstractBACKGROUND: The burden of diabetes and cardiovascular risk is not uniform across the USA, with much of this disparity tracking differences in socioeconomic status, cultural practices and lifestyle. To further evaluate disparities in these disorders, we assessed the prevalence of diabetes, hypertension, and hypercholesterolemia in an Old Order Amish community that is characterized by distinctive sociocultural practices that include a very cohesive social structure and limited use of modern technologies and medications. We compared prevalence of these conditions with that of the overall US population. METHOD: We performed a community-wide survey in 5377 Amish individuals aged 18 years and older from the Lancaster County, Pennsylvania, Amish settlement that included a basic physical examination and fasting blood draw during the period 2010-2018. We then compared the prevalence of diabetes, hypertension, and high cholesterol, defined using standard criteria, between the Amish and the European Caucasian subsample of the 2013-2014 US National Health and Nutrition Examination Survey (NHANES). RESULTS: Prevalence rates for diabetes, hypertension and hypercholesterolemia were 3.3%, 12.7%, and 26.2% in the Amish compared with 13.2%, 37.8% and 35.7% in NHANES (p<0.001 for all). Among individuals with these disorders, Amish were less likely to be aware that they were affected, and among those aware, were less likely to be treated with a medication for their disorder. CONCLUSION: There is substantially lower prevalence of diabetes, hypertension and hypercholesterolemia in the Amish compared with non-Amish Caucasians in the USA. Possible factors contributing to this disparity include higher physical activity levels in the Amish or other protective sociocultural factors, a greater understanding of which could inform risk reduction interventions for these chronic diseases.
Rights/Terms© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/13659
- Characterising the extent of misreporting of high blood pressure, high cholesterol, and diabetes using the Australian Health Survey.
- Authors: Peterson KL, Jacobs JP, Allender S, Alston LV, Nichols M
- Issue date: 2016 Aug 2
- Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998-2012.
- Authors: Kim HJ, Kim Y, Cho Y, Jun B, Oh KW
- Issue date: 2014 Jun 1
- Medication use for diabetes, hypertension, and hypercholesterolemia from 1988-1994 to 2001-2006.
- Authors: King DE, Ellis TM, Everett CJ, Mainous AG 3rd
- Issue date: 2009 Nov
- Treating hypertension to reduce cardiovascular risk: a Korean perspective.
- Authors: Kim KI, Kim CH
- Issue date: 2012 Jul
- Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia.
- Authors: Bays HE, Chapman RH, Fox KM, Grandy S, SHIELD Study Group
- Issue date: 2008 Apr